According to Gram Research analysis, a 2026 study found that a gene called SLC39A11 affects fatty liver disease very differently in females compared to males, with female hormones playing a key role in this sex difference. In female mice, having too much of this gene in the liver worsened fatty liver disease, while having less of it provided protection—effects that didn’t occur in males. This discovery suggests that future treatments for fatty liver disease may need to be designed differently for women and men.
Scientists discovered that a specific gene called SLC39A11 works differently in female and male livers, affecting how the body processes fat and handles liver disease. Using specially engineered mice, researchers found that this gene plays a much bigger role in female liver health, particularly when the liver is stressed by a special diet. The findings suggest that hormones like estrogen influence how this gene works, and that the gut and liver communicate differently between sexes. This discovery could lead to new treatments for fatty liver disease that work better for women than current options.
Key Statistics
A 2026 research article published in the Journal of Genetics and Genomics found that the SLC39A11 gene is significantly associated with fatty liver disease pathways only in female mice, revealing a sex-specific genetic mechanism not present in males.
Female mice with extra SLC39A11 in their livers developed more severe liver injury and cholestasis when fed a methionine/choline-deficient diet, while female mice with less of this gene showed attenuated liver damage—a pattern not observed in male mice.
Removing the ovaries from female mice largely reversed the protective or harmful effects of SLC39A11 changes, demonstrating that female sex hormones are essential to how this gene influences liver health.
The Quick Take
- What they studied: How a gene called SLC39A11 affects liver health differently in females versus males, especially when the liver is under stress
- Who participated: Laboratory mice that were genetically modified to have more or less of the SLC39A11 gene in their livers or intestines, compared in both males and females
- Key finding: In female mice, having too much SLC39A11 in the liver made fatty liver disease worse, while having less of it protected the liver. These effects didn’t happen in male mice, showing a clear sex difference
- What it means for you: This research suggests that treatments for fatty liver disease might need to be different for women and men. However, this is early-stage research in mice, so human studies are needed before any new treatments can be developed
The Research Details
Researchers used advanced genetic techniques to create special mice with extra or missing copies of the SLC39A11 gene in specific organs. They made some mice with more of this gene in their livers, some with less, and some with changes in their intestines instead. They then fed these mice a special diet designed to trigger fatty liver disease and watched what happened to their livers over time.
The scientists compared how male and female mice responded differently to these genetic changes. They also removed the ovaries from some female mice to see if female hormones (estrogen) played a role in how the gene worked. This approach allowed them to isolate exactly which organ the gene was important in and whether sex hormones mattered.
This research design is important because it goes beyond just looking at genes—it actually tests what happens when you change genes in living animals. By testing both males and females separately, the researchers could discover that the same gene has completely different effects depending on sex. This is a critical finding because many medical studies don’t look at sex differences carefully enough.
This study used well-established genetic engineering techniques and controlled experiments with proper comparison groups. The researchers tested their findings in multiple ways (liver-specific changes and intestine-specific changes) to make sure their results were reliable. However, because this is mouse research, the findings need to be confirmed in human studies before they can change medical practice. The study was published in a peer-reviewed scientific journal, meaning other experts reviewed it before publication.
What the Results Show
When female mice had extra SLC39A11 in their livers and were fed a diet that triggers fatty liver disease, they developed much worse liver damage and a condition called cholestasis (where bile gets stuck in the liver). Surprisingly, when female mice had less SLC39A11 in their livers, their livers were actually protected—they had less damage even on the harmful diet.
Male mice showed the opposite pattern: the amount of SLC39A11 in their livers didn’t significantly change how much liver damage they got. This sex difference was striking and unexpected. When researchers removed the ovaries from female mice (eliminating estrogen production), the protective or harmful effects of SLC39A11 largely disappeared, suggesting that female hormones are crucial to how this gene works.
Interestingly, when the gene was changed in the intestines instead of the liver, the pattern flipped. Female mice with extra intestinal SLC39A11 had less liver damage, while female mice with less intestinal SLC39A11 had more damage. Again, male mice didn’t show these intestinal effects. This suggests the gene works through communication between the gut and liver, but only in females.
The research points to two possible mechanisms: the gene may affect how manganese (a mineral important for metabolism) is handled in the body, and it definitely involves estrogen signaling pathways. The fact that removing ovaries reversed many of the effects confirms that female sex hormones are essential to understanding how this gene works. The gut-liver communication finding is particularly interesting because it suggests the intestines can influence liver health through this gene, but this pathway seems to be female-specific.
Previous research has shown that men and women get fatty liver disease at different rates and with different severity, but the reasons weren’t well understood. This study provides a specific genetic mechanism that could explain some of these sex differences. The finding that a single gene can have opposite effects in males versus females is consistent with growing evidence that many diseases affect men and women differently due to genetic and hormonal factors.
The biggest limitation is that this research was done in mice, not humans. Mouse livers work similarly to human livers in many ways, but not perfectly. The study used a specific diet to trigger liver disease that may not exactly match how fatty liver disease develops in people. Additionally, the sample sizes for individual experiments weren’t specified in the abstract, so we can’t fully assess statistical power. Finally, this research only looked at one gene; in real life, many genes and environmental factors influence liver health.
The Bottom Line
Based on this research, there is moderate confidence that SLC39A11 could be a target for new fatty liver disease treatments, but only after human studies confirm these findings. Current recommendations for fatty liver disease prevention (maintaining healthy weight, limiting alcohol, eating a balanced diet) remain the best approach. Women and men may eventually benefit from different treatment strategies based on this gene, but that’s not yet ready for clinical use.
This research is most relevant to people with fatty liver disease or at risk for it, particularly women. It’s also important for researchers studying sex differences in disease and for pharmaceutical companies developing new treatments. Men with fatty liver disease should know that their condition may work differently at the genetic level, which could eventually lead to better treatments tailored to their sex.
If this research leads to human clinical trials, it would likely take 5-10 years before any new treatments based on SLC39A11 become available. In the meantime, the best approach is to follow proven prevention strategies and work with doctors on current treatment options.
Frequently Asked Questions
Why do women and men get fatty liver disease differently?
A 2026 study found that a gene called SLC39A11 works very differently in female versus male livers, affecting how each sex processes fat. Female hormones like estrogen control how this gene functions, which may explain why men and women experience fatty liver disease at different rates and severity levels.
Can I change my SLC39A11 gene to prevent fatty liver disease?
You cannot currently change your genes, but understanding how SLC39A11 works may lead to new medications in the future. For now, proven prevention methods like maintaining a healthy weight, eating nutritious foods, and limiting alcohol remain your best options for protecting your liver.
Does this research mean women need different liver disease treatments than men?
This mouse research suggests that future treatments may need to be tailored by sex, but human studies haven’t confirmed this yet. Current fatty liver disease treatments work for both men and women, though individual responses vary. Talk to your doctor about the best approach for your situation.
How does the gut affect the liver through this SLC39A11 gene?
The study found that when female mice had extra SLC39A11 in their intestines, their livers were actually protected from damage. This suggests the intestines and liver communicate through this gene, but only in females. This gut-liver connection is an emerging area of research with potential treatment implications.
When will treatments based on this research be available?
This is early-stage research in mice. If it leads to human trials, new treatments would likely take 5-10 years to develop and approve. Current proven strategies for liver health—diet, exercise, weight management, and limiting alcohol—remain your best options today.
Want to Apply This Research?
- Track liver health markers monthly: weight, waist circumference, and energy levels. If users have access to blood work, monitor ALT and AST liver enzymes quarterly to catch changes early
- Log daily food choices focusing on liver-friendly foods (vegetables, lean proteins, whole grains) and track alcohol consumption. Set reminders for consistent meal timing, as regular eating patterns support liver metabolism
- Create a monthly liver health dashboard showing trends in weight, activity level, and dietary choices. Alert users to discuss results with their doctor if they notice negative trends, especially important for women given the sex-specific findings
This research was conducted in laboratory mice and has not yet been tested in humans. The findings are preliminary and should not be used to change your current medical treatment or diagnosis. If you have fatty liver disease or are concerned about liver health, consult with your healthcare provider about evidence-based prevention and treatment options. This article is for educational purposes only and does not constitute medical advice. Sex-specific treatments based on SLC39A11 are not yet available for human use.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.